A protocol for the determination of cyclosporine A in concentrations d
own to 10 ng/300 mg of cutaneous scales is described, using a liquid-l
iquid extractive prepurification followed by two-dimensional HPLC anal
ysis on Spherisorb Alumina PC18 and LiChrospher RP-18 columns.